急症高血压的优先之选44.pptxVIP

急症高压 尼 卡 地 平 注 射 液 首要之选 Deshmukh A,Kumar G,Kumar N,et al.Effect of Joint National Committee Vll report on hospitalization for hypertensive emergencies in the United States.Am J Card2011;108:1277-82 Katz JN,Gore JM,Amin A,et al.Practice patterns,outcomes,and end-organ dysfunction for patients with acute sever hypertension:the studying the treatment of acute hypertension(STAT)registry.Am Heart J 2009;158:599-606.. 急症高血压的病情风险情况 Slovis CM,Reddi AS.Increased blood pressure without evidence of acute end organ damage.Ann Emerg Med. 2008;51(3 Suppl):S7-9. 急症高血压伴各系统发病的风险情况 Connon CM,Levy P,Baumann BM,et al.Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial .BMJ Open 2013;3:e002338.doi:10.1136/bmjopen-2012-002338. Connon CM,Levy P,Baumann BM,et al.Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial .BMJ Open 2013;3:e002338.doi:10.1136/bmjopen-2012-002338. 备注:AUC面积均值越小,控制血压在降低过程中的变异性就越低,降压就越安全 备注:在用药30min上两者的SBP-TR(收缩压降压目标范围) 达到了显著性差异的水平*p=0.01＜p=0.05 Connon CM,Levy P,Baumann BM,et al.Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial .BMJ Open 2013;3:e002338.doi:10.1136/bmjopen-2012-002338. 备注:急症高血压降压治疗30min 中的TR(降压范围目标)上比较,在OR(优胜比数值)上佩尔是拉贝洛尔的3.65倍 Connon CM,Levy P,Baumann BM,et al.Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial .BMJ Open 2013;3:e002338.doi:10.1136/bmjopen-2012-002338. 降压精准 30min快速降压精准度高 安全有效 30min控制降压变异性小、安全性高 用药方式 配液方法 泵注 30ml佩尔®